BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 34205420)

  • 1. Multidimensional Regulation of Cardiac Mitochondrial Potassium Channels.
    Kulawiak B; Bednarczyk P; Szewczyk A
    Cells; 2021 Jun; 10(6):. PubMed ID: 34205420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global knockout of ROMK potassium channel worsens cardiac ischemia-reperfusion injury but cardiomyocyte-specific knockout does not: Implications for the identity of mitoKATP.
    Papanicolaou KN; Ashok D; Liu T; Bauer TM; Sun J; Li Z; da Costa E; D'Orleans CC; Nathan S; Lefer DJ; Murphy E; Paolocci N; Foster DB; O'Rourke B
    J Mol Cell Cardiol; 2020 Feb; 139():176-189. PubMed ID: 32004507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.
    Smith CO; Nehrke K; Brookes PS
    Biochem J; 2017 Jun; 474(12):2067-2094. PubMed ID: 28600454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning limits mitochondrial Ca(2+) during ischemia in rat hearts: role of K(ATP) channels.
    Wang L; Cherednichenko G; Hernandez L; Halow J; Camacho SA; Figueredo V; Schaefer S
    Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2321-8. PubMed ID: 11299237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection.
    Wang X; Fisher PW; Xi L; Kukreja RC
    J Mol Cell Cardiol; 2008 Jan; 44(1):105-13. PubMed ID: 18021798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioenergetic consequences of opening the ATP-sensitive K(+) channel of heart mitochondria.
    Kowaltowski AJ; Seetharaman S; Paucek P; Garlid KD
    Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H649-57. PubMed ID: 11158963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart.
    Shinohara T; Takahashi N; Kohno H; Yamanaka K; Ooie T; Wakisaka O; Murozono Y; Taniguchi Y; Torigoe Y; Hara M; Shimada T; Saikawa T; Yoshimatsu H
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1892-9. PubMed ID: 17586615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria "THE" target of myocardial conditioning.
    Boengler K; Lochnit G; Schulz R
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1215-H1231. PubMed ID: 30004243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits.
    Salloum FN; Takenoshita Y; Ockaili RA; Daoud VP; Chou E; Yoshida K; Kukreja RC
    J Mol Cell Cardiol; 2007 Feb; 42(2):453-8. PubMed ID: 17157308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
    Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
    Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection.
    Garlid KD; Dos Santos P; Xie ZJ; Costa AD; Paucek P
    Biochim Biophys Acta; 2003 Sep; 1606(1-3):1-21. PubMed ID: 14507424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear-encoded mitochondrial proteins and their role in cardioprotection.
    Boengler K; Heusch G; Schulz R
    Biochim Biophys Acta; 2011 Jul; 1813(7):1286-94. PubMed ID: 21255616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
    Das B; Sarkar C
    Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore.
    Alizadeh AM; Faghihi M; Khori V; Sohanaki H; Pourkhalili K; Mohammadghasemi F; Mohsenikia M
    Peptides; 2012 Jul; 36(1):71-7. PubMed ID: 22504012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCUb Induction Protects the Heart From Postischemic Remodeling.
    Huo J; Lu S; Kwong JQ; Bround MJ; Grimes KM; Sargent MA; Brown ME; Davis ME; Bers DM; Molkentin JD
    Circ Res; 2020 Jul; 127(3):379-390. PubMed ID: 32299299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial K+ transport and cardiac protection during ischemia/reperfusion.
    Carreira RS; Facundo HT; Kowaltowski AJ
    Braz J Med Biol Res; 2005 Mar; 38(3):345-52. PubMed ID: 15761613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mitochondrial permeability transition pore and mitochondrial ATP-sensitive potassium channels in the protective effects of ischemic preconditioning in isolated hearts from fed and fasted rats.
    Prendes MG; Hermann R; Torresin ME; Vélez D; Savino EA; Varela A
    J Physiol Biochem; 2014 Sep; 70(3):791-800. PubMed ID: 25034332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels.
    Stroethoff M; Christoph I; Behmenburg F; Raupach A; Bunte S; Senpolat S; Heinen A; Hollmann MW; Mathes A; Huhn R
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):106-111. PubMed ID: 29787401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial potassium channels as pharmacological target for cardioprotective drugs.
    Testai L; Rapposelli S; Martelli A; Breschi MC; Calderone V
    Med Res Rev; 2015 May; 35(3):520-53. PubMed ID: 25346462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.